Key points are not available for this paper at this time.
Design
Editorial
No takes yet. Share an insight, caveat, or question.
Highlights the lack of high-quality evidence that secondary penicillin prophylaxis reduces rheumatic heart disease progression and suggests alternative pathogenic mechanisms may be involved.
Karthikeyan et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: